Artis BioSolutions announced the launch of its Genetics Medicines Center of Excellence in Bilbao, Spain, where it already has a facility specializing in synthetic DNA manufacturing. The company, which also has facilities in Boston and San Diego, supports genetic medicine developers with manufacturing processes. It was cofounded by Harvard University, MIT and Boston research hospitals as Landmark Bio.…
Bristol Myers Squibb’s RazyeBio to build $173 million Indiana facility
RayzeBio, a subsidiary of Bristol Myers Squibb, announced plans to construct a new $173 million facility in Whitestown, Indiana. The 225,000-square-foot facility will be located at the Anson Industrial Park in Boone County and will manufacture radiopharmaceutical therapies (RPTs). Construction is expected to begin this year. The company currently has a 77,000-square-foot RPT supply and manufacturing facility…
Bristol Myers Squibb to build new plant in Houston
Bristol Myers Squibb (NYSE: BMY) announced it has selected Houston as the site for a new 600,000-square-foot multi-modal manufacturing campus, representing an approximately $2.3 billion investment. The campus, at Generation Park in Houston, will create nearly 500 skilled jobs, the company said. The campus’ multi-modal capabilities will allow BMS to manufacture multiple types of medicines – such as…